title: Tuberculosis preventative treatment also prevented diarrhoea in HIV-infected patients in Zambia.
authors.forename: Alwyn
authors.initials: A
authors.lastname: Mwinga
authors.forename: Maria
authors.initials: M
authors.lastname: Hosp
authors.forename: Isaac
authors.initials: I
authors.lastname: Zulu
authors.forename: Michael J G
authors.initials: MJ
authors.lastname: Farthing
authors.forename: Sylvia
authors.initials: S
authors.lastname: Mulambo
authors.forename: Paul
authors.initials: P
authors.lastname: Kelly
mesh_terms: D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003967:Diarrhea / Q000453:epidemiology / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D015994:Incidence; D007538:Isoniazid / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use*; D012189:Retrospective Studies; D012293:Rifampin / Q000627:therapeutic use*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000517:prevention & control*; D015024:Zambia / Q000453:epidemiology
chemical_list: D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin